Suppr超能文献

亚洲地区老年抗抑郁药治疗患者中同时使用抗精神病药物的情况。

Concurrent antipsychotic use in older adults treated with antidepressants in Asia.

机构信息

Unit of Psychiatry, Faculty of Health Sciences, University of Macau, Macao SAR, China.

Department of Neurosurgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

出版信息

Psychogeriatrics. 2019 Jul;19(4):333-339. doi: 10.1111/psyg.12416. Epub 2019 Feb 7.

Abstract

AIM

Depressive disorders are common in old age. Antipsychotics (APs) are often used as an adjunctive treatment with antidepressants (ADs) in this population but its patterns of use in Asia are not known. This study explored the rate of combination of APs and ADs in older adult psychiatric patients in Asia.

METHODS

This is a secondary analysis of the database of a multicentre study which recorded participants' basic demographical and clinical data in standardised format in 10 Asian countries and territories. The data were analysed using univariate and multivariate logistic regression analyses.

RESULTS

A total of 955 older adult psychiatric in- and outpatients were included in this study. The proportion of concurrent AP and AD use was 32.0%, ranging from 23.3% in Korea to 44.0% in Taiwan. Multivariate logistic regression analysis found that younger age, inpatient status and diagnosis of schizophrenia, anxiety and other mental disorders were significantly related to a higher proportion of concurrent use of APs and ADs.

CONCLUSION

Around a third of older adult psychiatric patients had concurrent AP and AD use in the Asian countries/regions surveyed. Considering the uncertain effectiveness and questionable safety of the AP and AD combination in this patient population, such should be cautiously used.

摘要

目的

抑郁障碍在老年人群中较为常见。在该人群中,抗精神病药(APs)常与抗抑郁药(ADs)联合使用作为辅助治疗,但亚洲地区的使用模式尚不清楚。本研究旨在探讨亚洲老年精神科患者中 APs 与 ADs 联合使用的比率。

方法

这是一项多中心研究数据库的二次分析,该研究以标准化格式记录了 10 个亚洲国家和地区的参与者的基本人口统计学和临床数据。采用单变量和多变量逻辑回归分析对数据进行分析。

结果

本研究共纳入 955 名老年精神科门诊和住院患者。同时使用 APs 和 ADs 的比例为 32.0%,范围为韩国的 23.3%至中国台湾的 44.0%。多变量逻辑回归分析发现,年龄较小、住院状态以及精神分裂症、焦虑症和其他精神障碍的诊断与更高比例的同时使用 APs 和 ADs 显著相关。

结论

在所调查的亚洲国家/地区,约有三分之一的老年精神科患者同时使用 APs 和 ADs。鉴于这种联合用药在该患者人群中的疗效不确定且安全性值得怀疑,应谨慎使用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验